Probability of emergence of antimalarial resistance in different stages of the parasite life cycle

Evolutionary Applications

Volumn 2, Issue 1, 2009, Pages 52-61

  Pongtavornpinyo, Wirichada ^a   Hastings, Ian M ^b   Dondorp, Arjen ^a,c   White, Lisa J ^a   Maude, Richard J ^a,c   Saralamba, Sompob ^a   Day, Nicholas P ^a,c   White, Nicholas J ^a,c   Boni, MacIej F ^d,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artemisinin; Bottleneck; De novo resistance; Drug resistance; Life cycle; Malaria; Population genetics; Resistance emergence

Indexed keywords

EID: 70350348409     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/j.1752-4571.2008.00067.x     Document Type: Article

References (34)

1. Adjuik, M., A. Babiker, P. Garner, P. Olliaro, W. Taylor, and N. White. 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363:9-17.
2. Ashley, E. A., and N. J. White. 2005. Artemisinin-based combinations. Current Opinion in Infectious Diseases 18:531-536.
3. Barnes, K. I., and N. J. White. 2005. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Tropica 94:230-240.
4. Boni, M. F., C. O. Buckee, and N. J. White. 2008a. Mathematical models for a new era of malaria eradication. PLoS Medicine 5:e231.
5. Boni, M. F., D. L. Smith, and R. Laxminarayan. 2008b. Benefits of using multiple first-line therapies against malaria. Proceedings of the National Academy of Sciences of the United States of America 105:14216-14221.
6. Buckling, A. G., L. H. Taylor, J. M. Carlton, and A. F. Read. 1997. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proceedings. Biological Sciences 264:553-559.
7. Cross, A. P., and B. Singer. 1991. Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 85:349-355.
8. Curtis, C. F., and L. N. Otoo. 1986. A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 80:889-892.
9. Dondorp, A., F. Nosten, K. Stepniewska, N. Day, and N. White. 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717-725.
10. Dye, C., and B. G. Williams. 1997. Multigenic drug resistance among inbred malaria parasites. Proceedings of the Royal Society of London. Series B: Biological Sciences 264:61-67.
11. Gatton, M. L., W. Hogarth, and A. Saul. 2001. Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections. Parasitology 123:537-546.
12. Hastings, I. M. 1997. A model for the origins and spread of drug-resistant malaria. Parasitology 115:133-141.
13. Hastings, I. M. 2004. The origins of antimalarial drug resistance. Trends in Parasitology 20:512-518.
14. Hastings, I. M., and W. M. Watkins. 2005. Intensity of malaria transmission and the evolution of drug resistance. Acta Tropica 94:218-229.
15. Hastings, I. M., P. G. Bray, and S. A. Ward. 2002a. Parasitology. A requiem for chloroquine. Science 298:74-75.
16. Hastings, I. M., W. M. Watkins, and N. J. White. 2002b. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 357:505-519.
17. Hutagalung, R., H. Htoo, P. Nwee, J. Arunkamomkiri, J. Zwang, V. I. Carrara, E. Ashley et al. 2006. A case-control auditory evaluation of patients treated with artemether- lumefantrine. American Journal of Tropical Medicine and Hygiene 74:211-214.
18. Hyde, J. E. 2002. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes and Infection 4:165-174
19. Institute of Medicine. 2004. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. The National Academies Press, Washington, DC.
20. Koella, J. C., and R. Antia. 2003. Epidemiological models for the spread of anti-malarial resistance. Malaria Journal 2:3.
21. Levin, B. R. 2002. Models for the spread of resistant pathogens. Netherlands Journal of Medicine 60:58-64.
22. Newton, P. N., B. J. Angus, W. Chierakul, A. Dondorp, R. Ruangveerayuth, K. Silamut, P. Teerapong et al. 2003. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clinical Infectious Diseases 37:7-16.
23. Paget-McNicol, S., and A. Saul. 2001. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology 122:497-505.
24. Pongtavornpinyo, W. 2006. Mathematical modelling of anti-malarial drug resistance. PhD Dissertation. Liverpool School of Tropical Medicine. Liverpool.
25. Price, R. N., F. Nosten, J. A. Simpson, C. Luxemburger, L. Phaipun, F. ter Kuile, M. van Vugt et al. 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 60:1019-1023.
26. Sibley, C. H., J. E. Hyde, P. F. Sims, C. V. Plowe, J. G. Kublin, E. K. Mberu, A. F. Cowman et al. 2001. Pyrimethamine- sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology 17:582-588.
27. Smithuis, F., M. K. Kyaw, O. Phe, K. Z. Aye, L. Htet, M. Barends, N. Lindegardh et al. 2006. Efficacy and effectiveness of dihydroartemisinin- piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet 367:2075-2085.
28. Stepniewska, K., and N. J. White. 2008. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrobial Agents and Chemotherapy 52:1589-1596.
29. Watkins, W. M., and M. Mosobo. 1993. Treatment of Plasmo- dium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene 87:75-78.
30. White, N. J. 2008. Qinghaosu (artemisinin): the price of success. Science 320:330-334.
31. White, N. J., and W. Pongtavornpinyo. 2003. The de novo selection of drug-resistant malaria parasites. Proceedings of the Royal Society of London. Series B: Biological Sciences 270:545-554.
32. White, N. J., D. Chapman, and G. Watt. 1992. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 86:590-597.
33. World Health Organisation (WHO). 2006. Guidelines for the Treatment of Malaria. WHO, Geneva, Switzerland.
34. Yeung, S., W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White. 2004. Antimalarial drug resistance, artemis- inin-based combination therapy, and the contribution of modeling to elucidating policy choices. American Journal of Tropical Medicine and Hygiene 71:179-186.